Ampio Pharmaceuticals, Inc.【AMPE】Cash flow
Market cap
$317.9K
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Depreciation & amortization | 42,551 | 104,947 | 242,627 | 439,098 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 122,000 |
| Stock-based compensation | 3 | 5 | 8 | 8 | 6 | 2 | 744,870 | 443,786 | 405,000 | 1 | 3 | 1 | 159,000 |
| Cash from operations | -9,131,662 | -9,715,163 | -19,133,157 | -30,740,583 | -26,444,110 | -14,624,972 | -11,407,947 | -12,138,023 | -15,383,000 | -15 | -14,089,000 | -21,128,000 | -8,564,000 |
| Capital expenditures | -84,705 | -84,705 | -1,396,088 | -8,668,351 | -235,656 | -6,844 | -72,325 | -564,276 | -22,000 | -63,000 | -97,000 | - | - |
| Cash from investing | -119,705 | 15,000 | -1,665,239 | -8,657,964 | -1,776,546 | -6,844 | -72,325 | -564,276 | -22,000 | -63,000 | -97,000 | - | - |
| Cash from financing | 25 | 41 | 70 | 63 | 5 | 4 | 15 | 12 | 14 | 26 | 31 | -111,000 | - |
| Free cash flow | - | - | |||||||||||
| FCF margin (%) | - | - | - | - | - | - | - | - | - | - | - | - |